Shi, H., Chu, Y., Yu, X., Li, J., Wang, H., & Xu, Y. (2025). Efficacy of halfdose aspirin in Kawasaki disease: Insights from a single center experience. AIMS Allergy & Immunology, 9(3), 1. https://doi.org/10.3934/allergy.2025012
Chicago Style (17th ed.) CitationShi, Huaxu, Yanqiu Chu, Xuexin Yu, Jinghao Li, Hong Wang, and Yunming Xu. "Efficacy of Halfdose Aspirin in Kawasaki Disease: Insights from a Single Center Experience." AIMS Allergy & Immunology 9, no. 3 (2025): 1. https://doi.org/10.3934/allergy.2025012.
MLA (9th ed.) CitationShi, Huaxu, et al. "Efficacy of Halfdose Aspirin in Kawasaki Disease: Insights from a Single Center Experience." AIMS Allergy & Immunology, vol. 9, no. 3, 2025, p. 1, https://doi.org/10.3934/allergy.2025012.
Warning: These citations may not always be 100% accurate.